Blog

Validation from Science Based Targets initiative demonstrates that the global leader in ITAD services is committed to mitigating climate change through sustainable business practices.

SINGAPORE, SG / ACCESS Newswire / September 29, 2025 / SK tes, a global leader in sustainable IT asset disposition (ITAD) and technology lifecycle services, announces that the Science Based Targets initiative has validated the company’s greenhouse gas (GHG) emissions inventory and reductions targets.

The action confirms that SK tes has developed plans that will allow the company to meet both its short-term emissions goals as well as its net-zero carbon by 2050 goal, and demonstrates that SK tes is committed to environmentally sustainable business practices.

“SBTi’s validation of our emissions targets shows that SK tes is committed to significantly reduce our carbon footprint, both from our internal processes and in how we do business with clients and partners worldwide,” said Alvin Piadasa, group sustainability director at SK tes.”As the first ITAD to make this commitment, we aim to inspire others to act — our impact goes beyond reuse; it drives real environmental change.”

With 40-plus facilities worldwide, SK tes assists clients in more than 100 countries in managing the commissioning, deployment, and retirement of technology devices and components. It provides comprehensive lifecycle services for technology devices, from deployment to decommissioning to disposition.

The Science Based Targets initiative and SBTi Services develop standards, tools and guidance based on the latest findings in climate science that allow organizations to reduce their greenhouse gas emissions to levels needed to prevent catastrophic global heating. Businesses that receive SBTi Services validation demonstrate to their customers and investors that they are taking responsibility for preventing the worst impacts of climate change.

The SK tes GHG emissions reduction targets, as validated by SBTI Services, include:

Near-term targets: Reduce absolute Scope 1 and 2 GHG emissions 42% by 2030 from a 2023 base year, and reduce scope 3 GHG emissions 51.6% per dollar of value add within the same timeframe.

Long-term targets: Reduce absolute Scope 1, 2 and 3 GHG emissions 90% by 2050 from a 2023 base year.

Overall Net-Zero Target: Commitment to reach net-zero greenhouse gas emissions across the value chain by 2050.

Scope 1 emissions are greenhouse gases that an organization emits from sources it owns or controls directly, such as exhaust from an engine or furnace. Scope 2 emissions are indirect, such as the organization’s purchase of electricity, steam, heat, or cooling produced by a utility or other generator.

Scope 3 emissions, also known as lifecycle or value chain emissions, include those generated across a product’s lifecycle — for example, fuel burned to manufacture or operate it, or emissions from employees commuting to work.

In baseline year 2023, SK tes emitted about 6,400 tons of Scope 1 and 2 GHG emissions and was responsible for another 54,600 tons of Scope 3 emissions. Under its targets, the company would reduce Scope 1 and 2 emissions to about 3,700 tons by 2030 and about 6000 tons by 2050. Scope 3 emissions intensity would fall to 28,000 tons by 2030 and absolute emissions by about 150,000 tons by 2050 taking into account compounded business growth.

In its validation report, SBTi concluded that SK tes’ “targeted near-term reduction between the base year and the most recent year leads to emissions reductions in line with a 1.5°C pathway,” the limit set in the international treaty on climate change known as the Paris Agreement, adopted by 195 nations in 2015.

“SK tes believes that the company and the planet are inextricably connected, and by creating a pathway that aligns with the targets of the Paris Agreement, we are taking action to ensure a bright and prosperous future for both,” Piadasa said.

To learn more about SK tes services and its commitment to sustainability, visit https://www.sktes.com/.

About SK tes

Since our formation in 2005, SK tes, a subsidiary of SK ecoplant, has grown to become a global leader in sustainable battery recycling and technology lifecycle services. We provide comprehensive services for battery recycling, extracting scarce materials from used batteries at purity rates high enough that they can be reused in the manufacturing supply chain.

SK tes has over 40 owned facilities across 22 countries offering unmatched service-level consistency, consistent commercials, lower logistics costs, local compliance experts in-region, support in local time zones and languages, and a deep understanding of transboundary movement globally.

SOURCE: SK tes

Related Images

View the original press release on ACCESS Newswire

NEW YORK, NY / ACCESS Newswire / September 29, 2025 / Three decades. Twenty-nine global conferences. Billions poured into hotels, banquets, travel, and stagecraft. And to be fair, these gatherings weren’t in vain. They brought the world’s attention to plastics, sustainability, and safety in a way that no single company or country could have done alone. Ambition was never the problem. The intent was real. But after all the speeches and pledges, what do we still see? Plastics burned instead of recycled. Landfills bursting at the seams. Safety standards that collapse under stress tests.

This is the cost of promises without proof – and it is staggering. Every ton of plastic incinerated instead of recycled carries not just an environmental price, but a financial one: wasted material, wasted energy, wasted opportunity. Every fire that spreads because a flame retardant existed only on paper brings lawsuits, insurance payouts, and communities left picking up the pieces. COP 29, like the 28 before it, showed the world can agree on goals. What it hasn’t delivered is the enforcement to back them up.

The world doesn’t need another set of pledges. It needs systems that can verify and enforce the pledges already made. That’s where technology steps in. And it’s why SMX (NASDAQ:SMX) is not waiting for the next plenary hall – it’s delivering enforcement at the molecular level today.

The Price Tag of 29 “To Be Continued” Episodes

Let’s talk numbers. The OECD estimates that plastic pollution already costs the global economy billions of dollars annually in clean-up, lost tourism, and health impacts. Recycling programs burn through public budgets but return little value when much of the material is unverifiable. Insurers and manufacturers spend billions more covering losses from materials that were marketed as safe but proved otherwise in real-world fires, such as the Grenfell and Lacrosse Tower tragedies.

What those losses share is a single root: lack of proof. Recycling programs collapse because no one can verify the content. Fire safety claims fail because datasheets are accepted as gospel instead of being tested in the field. For thirty years, conferences promised to bridge that gap. They never did. The receipts of inaction are piling up in lawsuits, landfill fees, and lost trust.

That is the economic hole SMX was designed to fill.

Proof That Pays; It’s Currency

By embedding molecular markers into plastics and materials, SMX transforms verification from an afterthought into the product itself. A single scan can confirm recycled content, prove the integrity of flame-retardant materials, and expose those under-the-radar plastics, such as carbon black, that once slipped through every recycling system.

This shift changes the math. Instead of regulators spending money to chase violators, markets reward verified compliance in real time. Verified recycled plastics command higher prices. Verified fire-resistant panels lower liability and insurance costs. And verified under-the-radar plastics, once written off as worthless, become tradable assets that re-enter supply chains.

Proof doesn’t just save money – it creates value. It turns circularity from a line item on a sustainability report into a revenue-generating, risk-reducing system that benefits governments, industries, and consumers alike.

Singapore, Europe, and expanding

This isn’t just theory. In Singapore, SMX has already partnered with A*STAR to roll out a national plastics passport. Every piece of plastic now carries a digital twin tied to molecular proof. Policymakers no longer have to accept self-reported recycling rates. They have enforcement embedded in the material itself.

Europe is next, where SMX’s planned collaboration with REDWAVE will bring verification onto factory floors. Instead of post-hoc audits, compliance becomes continuous and live. Even those pesky plastics that haunted the system for decades are tracked, verified, and priced.

And in North America, interest from the North American Flame Retardant Alliance (NAFRA) extends this system into fire safety. A scan verifies flame-retardant protection in real time, turning one of the most lawsuit-prone industries into one of the most enforceable.

The Price of Inaction is Too High

COP 29 should have been the wake-up call, but the truth is it was just another expensive snooze button. The world doesn’t need more rhetoric. It doesn’t need more glossy targets. It needs proof that works in the field, on the factory floor, and in the marketplace.

That’s what SMX is delivering. Proof that stops billions from being wasted on incineration and landfills. Proof that reduces the liability of catastrophic fires. Proof that turns once-buried plastics into verified commodities. Proof that makes circularity enforceable instead of aspirational.

Three decades of inaction have cost the world enough. The next decade must be different. With SMX’s molecular markers, it can finally be: One scan. Two proofs. Inaction priced out of existence.

About SMX

As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company’s fight against abusive and possibly illegal trading tactics against the Company’s stock; successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of gold, steel, rubber and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

EMAIL: info@securitymattersltd.com

SOURCE: SMX (Security Matters)

View the original press release on ACCESS Newswire

FRISCO, TEXAS / ACCESS Newswire / September 29, 2025 / GameSquare Holdings, Inc. (NASDAQ:GAME) (“GameSquare” or the “Company”) reminds shareholders of record as of September 5, 2025 of the Company’s upcoming annual meeting, which will be held on October 7, 2025 at 12:00 p.m. CT. Shareholders of record as of September 5, 2025 will be able to attend the Annual Meeting virtually by visiting https://meetnow.global/M2RRVHC.

Shareholders are advised to vote their shares well in advance of the proxy voting deadline of 11:59 p.m. CT, on October 6, 2025. The proposals are included in the definitive proxy statement filed with the U.S. Securities and Exchange Commission. The proxy statement is available at: https://www.sec.gov/ix?doc=/Archives/edgar/data/1714562/000164117225026855/formdef14a.htm

YOUR VOTE IS IMPORTANT NO MATTER HOW MANY SHARES YOU HOLD.

THE BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE FOR ALL DIRECTOR NOMINEES AND PROPOSED RESOLUTIONS

Key Proxy Proposal: Technical Statutory Merger
One of the proposals this year is the approval of a statutory merger with a wholly owned subsidiary. GameSquare will remain the surviving entity. This is a technical reorganization only and not a new merger or acquisition. The primary purpose of the merger is to adopt a restated set of articles of incorporation, which will provide the Company with greater flexibility to pursue future growth and opportunities.

Approval of this proposal will allow GameSquare to:

• Modernize and simplify its governing documents

• Provide flexibility to support future growth and capital markets initiatives

• Align its governance framework with current market practices

Other Proxy Proposals
In addition to the statutory merger, shareholders are being asked to consider:

• Election of Directors with the expertise to provide strong oversight and leadership

• Ratification of Independent Auditors to reinforce confidence in GameSquare’s financial reporting

• Equity and Governance Matters that support attracting and retaining talent, aligning management incentives with shareholders, and strengthening corporate governance

Your Vote Matters
Every shareholder’s vote is important, regardless of the number of shares owned. Shareholders are strongly encouraged to vote as soon as possible online, by telephone, or by mailing their proxy card, as outlined in the proxy materials.

Shareholder Questions and Voting Assistance
Shareholders who have any questions or require assistance with voting may contact the Company’s proxy solicitation agent and shareholder communications advisor:

Laurel Hill Advisory Group
Toll Free (North America): 1-888.742.1305
International: +1-416-304-0211
By Email: Jdepinto@laurelhill.com

About GameSquare Holdings, Inc.
GameSquare (NASDAQ: GAME) is a cutting-edge media, entertainment, and technology company transforming how brands and publishers connect with Gen Z, Gen Alpha, and Millennial audiences. With a platform that spans award-winning creative services, advanced analytics, and FaZe Clan Esports, one of the most iconic gaming organizations, we operate one of the largest gaming media networks in North America. As a digital-native business, GameSquare provides brands with unparalleled access to world-class creators and talent, delivering authentic connections across gaming, esports, and youth culture. Complementing our operating strategy, GameSquare has developed an innovative treasury management program designed to generate yield and enhance capital efficiency, reinforcing our commitment to building a dynamic, high-performing media company at the intersection of culture, technology, and next-generation financial innovation.

To learn more, visit www.gamesquare.com.

Forward-Looking Information

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the Company’s future performance, returns generated by its business strategies, revenue, growth and profitability; and the Company’s ability to execute on its current and future business plans. These forward-looking statements are provided only to provide information currently available to us and are not intended to serve as and must not be relied on by any investor as, a guarantee, assurance or definitive statement of fact or probability. Forward-looking statements are necessarily based upon a number of estimates and assumptions which include, but are not limited to: the Company’s 2025 annual meeting of shareholders (the “Annual Meeting”) and corporate governance, the Company’s ability to grow its business and being able to execute on its business plans and strategies, the success of Company’s vendors and partners in their provision of services to the Company, the Company being able to recognize and capitalize on opportunities and the Company continuing to attract qualified personnel to supports its development requirements. These assumptions, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: the Company’s annual meeting and corporate governance, its ability to achieve its objectives, the Company successfully executing its growth strategy, the ability of the Company to obtain future financings or complete offerings on acceptable terms, failure to leverage the Company’s portfolio across entertainment and media platforms, dependence on the Company’s key personnel and general business, economic, competitive, political and social uncertainties. These risk factors are not intended to represent a complete list of the factors that could affect the Company which are discussed in the Company’s most recent MD&A. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. GameSquare assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

Corporate Contact
Lou Schwartz, President
Phone: (216) 464-6400
Email: ir@gamesquare.com

Investor Relations
Andrew Berger
Phone: (216) 464-6400
Email: ir@gamesquare.com

Media Relations
Chelsey Northern / The Untold
Phone: (254) 855-4028
Email: pr@gamesquare.com

SOURCE: GameSquare Holdings, Inc.

View the original press release on ACCESS Newswire

New facility enhances service reach across Nebraska, Southwest Iowa, and surrounding markets

GREENVILLE, SOUTH CAROLINA / ACCESS Newswire / September 29, 2025 / Cameron Ashley Building Products (Cameron Ashley) has expanded its Midwest presence with the opening of a new distribution center in Omaha, Nebraska, giving customers faster, more reliable access to insulation, roofing, siding, wallboard and all related accessories.

“Omaha and the surrounding region are seeing steady growth in both residential and commercial construction,” said Warren Michaelson, Regional Vice President. “With this new location, we can provide local customers with quicker access to our products and services, supported by a dedicated team that truly understands the market. This expansion also reinforces our strategy of having the right products in stock, near our customers, and delivered fast.”

“This new location positions us to grow with our customers as the region’s construction activity continues to thrive,” Michaelson added.

Mike Herwig, Omaha Distribution Center Manager, noted, “Cameron Ashley is committed to combining product expertise with unmatched service. Our Omaha team is ready to provide customers with the knowledge, tools, and support to keep projects moving without delays.”

With this addition, Cameron Ashley strengthens its Midwest network, providing enhanced service coverage to customers across Nebraska, Southwest Iowa, and beyond.

About Cameron Ashley Building Products, Inc.

Cameron Ashley is a leading wholesale distributor of roofing, insulation, gypsum, siding, and other specialty building products. We deliver a premier portfolio of nationally recognized brands to customers across the lumber and building materials industry. With more than 70 distribution centers nationwide, we stock large volumes of building products locally and offer flexible, customer-centric delivery options through our F^ST same-day or next-day delivery platforms. Our relationship-driven approach includes the industry-leading PLUS® Points loyalty program, free merchandising support, as well as exclusive purchasing and show incentives. Customers can shop anytime through either our CONNECT online portal or mobile app, which provide real-time access to product availability, pricing, order history, secure payments, and detailed product specs and warranties. To learn more or place an order, visit cameronashleybp.com.

Contact Information

Sara Eller
VP Marketing
saraeller@cameronashleybp.com
864-281-3687

SOURCE: Cameron Ashley Building Products

View the original press release on ACCESS Newswire

Businesses face heightened fines in 2025 as the IRS steps up enforcement on worker classification errors

IRVINE, CA / ACCESS Newswire / September 29, 2025 / The IRS is increasing penalties for businesses that misclassify employees as independent contractors, a move that could significantly raise costs for employers who fail to follow proper guidelines. The change comes as the agency intensifies efforts to ensure payroll tax compliance, especially in industries that rely heavily on gig or contract labor.

“Misclassifying workers isn’t just a paperwork mistake – it can lead to thousands in back taxes, interest, and penalties,” said a spokesperson for Clear Start Tax. “The IRS is sending a strong signal in 2025 that businesses need to take classification rules seriously.”

Clear Start Tax noted that companies often misclassify workers to avoid paying payroll taxes, unemployment insurance, and benefits. However, the IRS has expanded its audit focus to spot patterns of abuse, relying on both tip-offs and advanced data analysis.

“Employers should not assume they can fly under the radar anymore,” the spokesperson added. “The IRS is paying close attention, and penalties are increasing. Properly determining whether a worker is an employee or an independent contractor is critical to avoiding serious consequences.”

By answering a few simple questions, taxpayers can find out if they’re eligible for the IRS Fresh Start Program and take the first step toward resolving their tax debt.

Small businesses, construction firms, and companies using large freelance networks are particularly at risk. Experts say the safest step is to review contracts and job duties under IRS guidelines before filing 2025 returns.

About Clear Start Tax
Clear Start Tax is a national tax resolution firm that helps individuals and businesses navigate complex IRS challenges. From audits and back taxes to payroll issues and tax relief programs, the firm provides tailored solutions to reduce risk and resolve debt while ensuring compliance.

Need Help With Back Taxes?
Click the link below:
https://clearstarttax.com/qualifytoday/
(888) 710-3533

Contact Information
Clear Start Tax
Corporate Communications Department
tech@clearstarttax.com
(949) 800-4011

SOURCE: Clear Start Tax

View the original press release on ACCESS Newswire

Two-thirds of executives plan to leave their current company, signaling a need to rethink succession planning and build stronger leadership pipelines.

NEW YORK CITY, NY / ACCESS Newswire / September 29, 2025 / LHH, the integrated professional talent solutions provider and global business unit of the Adecco Group, today releases its report reviewing the current state of executive search and transition processes.

View from the C-Suite: Executive Talent Strategies for a New Era, draws on perspectives from more than 4,600 executives worldwide and highlights the trends reshaping leadership, from evolving career paths to the skills organizations value most in a rapidly changing business environment. The report also outlines strategies for building leadership teams capable of navigating complexity, driving transformation, and creating lasting impact.

Nearly six in ten executives expect to make a career move within the next three years, indicating a need for organizations to future-proof leadership strategies with succession planning and talent strategies that retain and develop top leaders. The report offers actionable insights to help organizations elevate executive search as a strategic priority, build world-class leadership teams, and equip leaders to succeed in an era of rapid change and unprecedented opportunity.

One in three newly appointed executives says they do not feel confident in their ability to perform within the first year of a new role, and almost just as many executives lack confidence in their leadership team’s ability to perform. Of the executives surveyed, 30% also indicated wanting to develop new skills as a top-rated reason for their departure. Trust, support and the ongoing skills-gaps across all stages of talent development, including leadership, point to broader overarching challenges of continued vacancies if there is risk of underprepared successors.

At the same time, the skill set organizations look for in leaders is shifting. Technical expertise is no longer the sole differentiator, but rather soft skills such as collaboration, strategic thinking and communication top the list of must-have qualities. Executives who can adapt, inspire and drive transformation are in highest demand, underscoring the value of human-centered leadership.

However, technology is still crucial to understanding the leaders at the forefront of workforce transformation. More than a third of executives say AI and digital fluency are the most critical capabilities for leadership teams. Leading AI success across organizations requires senior leaders who can integrate the technology responsibly, aligned with strategy and scale across the enterprise.

“Leadership is being redefined. To stay ahead, organizations need executive talent strategies that identify and recruit leaders with the right skills and provide the right support, empathy and partnership they need to succeed in complex, changing environments,” says Nicole Gable, North America Recruitment Solutions president at LHH. “The executives who make the biggest impact are those who blend human-centered skills with the ability to leverage technology to communicate vision, drive results and lead with purpose.”

As the trusted leader in executive search, LHH connects organizations to leaders who bring expertise, passion and fresh perspectives. With a distinctly human approach and a focus on long-term partnerships, LHH delivers a boutique experience that creates long-lasting, strategic leadership outcomes from Executive Search to Executive Interim Management and leadership workforce planning from Talent Mapping to Executive Assessments.

To read the full report and learn more about LHH Executive Search, visit: https://info.lhh.com/gbl/en/executive-search

###

About LHH

LHH empowers professionals and organizations to achieve bold ambitions and secure lasting impact through unique advisory services and professional talent solutions.

LHH’s full suite of offerings connects solutions that are traditionally siloed, making LHH a single talent partner for organizations. In a rapidly evolving landscape with complex challenges, we create value across the entire professional talent journey. From hiring great people, developing skills and nurturing leaders, to advancing individuals to the next stage of their careers, LHH makes talent a competitive edge.

We believe the future of work lies at the intersection of exceptional human care and innovation. Powered by science, technology and proprietary data analytics, LHH’s approach is crafted to align with business strategies and cultures, delivering powerful, sustainable and measurable impact.

LHH has a team of over 12,000 professionals, across 60+ countries and more than 50 years of experience. As part of the Adecco Group, we bring together global excellence, local knowledge and centralized coordination for thousands of companies and millions of people worldwide.

Recruitment. Development. Career Transition.

LHH. A beautiful working world.

To learn more about LHH, visit: lhh.com.

Media Contact

PR@lhh.com

SOURCE: LHH

View the original press release on ACCESS Newswire

FORT LAUDERDALE, FL / ACCESS Newswire / September 29, 2025 / Vision Marine Technologies Inc. (NASDAQ:VMAR) (“Vision Marine” or the “Company”), a company specializing in marine innovation across electric and internal combustion platforms, together with its Nautical Ventures division, announced today milestone activations for the 2025 Fort Lauderdale International Boat Show (FLIBS), including a VIP shuttle service operated with Vision Marine’s electric boats and a reimagined AquaZone™ developed in collaboration with AquaBanas and Informa Markets.

FLIBS owned by the Marine Industries Association of South Florida produced by Informa Markets, is the largest in-water boat show in the United States and one of the most prestigious marine events worldwide, attracting more than 100,000 visitors annually. With more than 450 exhibitions globally, Informa has built FLIBS into the premier stage for boating innovation.

This year’s AquaZone™ will debut in a brand-new floating island format, made possible through AquaBanas’ modular platform system. Presented as a show within the show, this year’s AquaZone™ is set to deliver the most immersive experience ever staged at FLIBS, combining live on-water demonstrations, direct consumer interaction, and hands-on access to innovative products in a dedicated destination at the docks.

The reimagined AquaZone™ will bring together:

• Vision Marine’s electric boat and technology portfolio.

• The newest lineup of EV toys and watersports products retailed by Nautical Ventures, reflecting the rollout of a dedicated electric division.

• A refreshed Nautical Ventures watersports and lifestyle offering, expanding its reach as a hub for marine innovation.

• Selected vendor and partner showcases, highlighting emerging marine technologies and new product debuts.

• Marine commodities, accessories, and lifestyle items curated to enhance the on-water experience.

For the first time, AquaZone™ will also introduce opportunities for attendees to purchase select boats and products directly on-site. This direct-to-consumer component supports Vision Marine’s retail adoption strategy and reinforces Nautical Ventures’ position as a distribution channel for electric propulsion and lifestyle marine products.

“By presenting the floating AquaZone™ at the docks of FLIBS and operating a VIP shuttle service powered by Vision Marine’s electric boats, we are expanding the way innovation is experienced at the show,” said Roger Moore, Founder of Nautical Ventures and Chief Revenue Officer. “This year’s AquaZone™ delivers the most immersive experience ever created at FLIBS, powered by Vision Marine’s electric lineup, AquaBanas’ floating island technology, and Nautical Ventures’ network of innovation.”

Informa Markets highlighted the significance of this year’s new format:
“FLIBS has always been the premier stage for boating innovation, and the AquaZone™ reflects our commitment to enhancing that experience,” said Andrew Doole, President of U.S. Boat Shows for Informa Markets. “By partnering with Nautical Ventures and AquaBanas, we are introducing a brand-new format that will engage consumers, dealers, and media in new ways.”

“The AquaZone™ demonstrates what is possible when Nautical Ventures’ disruptive marketing meets Vision Marine’s adoption platform and Informa’s global leadership,” added Alexandre Mongeon, CEO and co-founder of Vision Marine. “It is both a milestone for this year’s show and a foundation for the commercialization of the E-Motion™ platform as electric boating adoption continues to accelerate.”

About Vision Marine Technologies Inc.
Vision Marine Technologies Inc. (NASDAQ: VMAR) is a disruptive marine company combining proprietary electric propulsion technology with multi-brand retail and service operations. The Company developed the world’s first industrialized high-voltage electric outboard powertrain, the E-Motion™ 180E, and has now achieved 24 integrations of this system across multiple recreational boat platforms. Vision Marine’s journey includes breaking the world electric speed record at 116 mph, operating a successful rental business in Newport Beach, California, and acquiring Nautical Ventures, one of the most recognized dealership networks in the United States. Today, Vision Marine delivers innovation both through its E-Motion™ propulsion technology and through the sale of premium electric and ICE boats via Nautical Ventures’ retail network.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as “anticipate,” “believe,” “expect,” “estimate,” “intend,” “project,” “forecast,” “plan,” “potential,” “may,” “should,” “will,” and similar expressions, or the negative of these terms or other comparable terminology. Forward-looking statements include, but are not limited to, statements regarding the Company’s business strategy, anticipated events at the Fort Lauderdale International Boat Show, commercialization plans, and market adoption. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. Vision Marine disclaims any obligation to update forward-looking statements except as required by law.

Investor Relations Contact
Bruce Nurse
(303) 919-2913
bn@v-mti.com
https://investors.visionmarinetechnologies.com

SOURCE: Vision Marine Technologies Inc

View the original press release on ACCESS Newswire

NEW YORK, NY / ACCESS Newswire / September 29, 2025 / Europe has long been the beating heart of global fashion, but now it intends to become the brain as well. While designers in Paris and Milan set the trends on the runway, the continent’s regulators have been setting just as aggressive targets behind the scenes. The EU’s Digital Product Passport rules, ESG mandates, and Green Deal initiatives all point to one thing: traceability is no longer optional. It’s the law. And the brands that want to thrive under this regime need more than ambition. They need proof.

That’s where the partnership between SMX (NASDAQ:SMX) and CETI, the European Center for Innovative Textiles, takes center stage. Based in Lille, CETI is a hub of R&D firepower, and SMX is bringing the molecular-level tech that finally turns recycling and authentication into measurable realities. By embedding invisible fingerprints into fibers and tying them to blockchain passports, they’re not talking about traceability in theory. They’re operationalizing it at an industrial scale. This isn’t about testing samples in a lab. It’s about creating market-ready fabrics that carry their credentials from the moment they leave the loom.

The implications are massive. Lille is now positioned as Europe’s launch pad for textile circularity, an epicenter where compliance meets competitiveness. The brands that plug into this system won’t just be checking regulatory boxes; they will also be leveraging the system to drive growth. They’ll be setting the global standard, exporting textiles with built-in trust that can cross borders, enter finance systems, and hold value in resale markets. Counterfeiters, once experts at slipping through loopholes, will find themselves locked out entirely. Europe’s message is clear: if it doesn’t carry proof, it doesn’t carry value.

Europe’s Competitive Edge

The Green Deal and Digital Product Passport requirements are no longer distant talking points. They’re active levers reshaping how textiles are produced, sold, and financed. For companies that comply, the rewards are enormous. Verified recycled content can fetch higher margins, sustainability reports suddenly become bulletproof, and ESG-linked financing starts flowing with lower risk premiums. CETI’s pilot lines turn compliance into a competitive edge, and SMX’s molecular markers make sure no counterfeit can piggyback off the system. In a sector where billions are lost to fake fabrics and fraudulent claims, that’s not just progress. It’s a paradigm shift.

Luxury fashion will benefit, but so will sportswear, industrial fabrics, and technical textiles. By embedding trust directly into the material, the entire ecosystem gains a multiplier effect. Supply chains move faster, regulators have enforceable data, and consumers gain confidence that the clothes on their backs are what they claim to be. Proof becomes Europe’s new export, not just the fabrics themselves. That’s how you win markets.

Platforms like eBay show why this matters globally. They already have rules in place to fight fakes, but rules aren’t enough without the tools to enforce them at speed and scale. Scanners tied to molecular markers would make their efforts airtight, instantly authenticating a watch, a handbag, or a jacket before it ever hits the buyer’s doorstep. Europe’s proof-first model is the playbook, and platforms everywhere will be forced to follow.

The New Standard

The counterfeit industry has thrived on gaps, exploiting weak enforcement and opaque supply chains. But Europe just closed the gap. Lille’s CETI, armed with SMX technology, isn’t running pilots for show. It’s demonstrating to the world that circularity can be verifiable, profitable, and enforceable. The EU’s leadership on this front isn’t just bureaucratic muscle. It’s the foundation of a new global textile economy, one where every fiber carries a passport and every recycled material commands its true price.

Fashion has always been about staying ahead, but this is different. This is about Europe using regulation and technology as weapons to protect its competitiveness and ensure standards are met, while simultaneously burying counterfeiters in the rubble of their old business model.

From luxury brands to industrial suppliers, the rules of the game just changed. And the scoreboard isn’t counting logos anymore. It’s counting the proof that SMX and CETI can provide.

About SMX

As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company’s fight against abusive and possibly illegal trading tactics against the Company’s stock; successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of gold, steel, rubber and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

EMAIL: info@securitymattersltd.com

SOURCE: SMX (Security Matters)

View the original press release on ACCESS Newswire

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays (D-MNA) representing ~$2 billion in potential market opportunity

The Company plans to complete patient recruitment for SKNJCT-003 before the end of Q4 2025 and to request End-of-Phase 2 (EOP2) with the FDA in Q1 2026

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / September 29, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce positive feedback from Type C meeting with United States Food and Drug Administration (FDA).

The purpose of the Type C meeting was to discuss the design, endpoints, and other key protocol elements for the clinical development of doxorubicin containing microneedle array (D-MNA) to non-invasively treat basal cell carcinoma (BCC) of the skin.

The FDA provided clarity and further alignment that a relative bioavailability study with the Company’s D-MNA product to treat BCC administered under certain conditions could provide support towards establishing a clinical bridge for the 505(b)(2) regulatory pathway as well as help satisfy the bioavailability requirement of the Company’s D-MNA product as stated in 21CFR320.21. More specifically, the FDA provided positive and constructive feedback on a number of topics for the continued development of Skinject including, but not limited to: the appropriate primary endpoint for the next study; proposed patient population definition, including tumor size limits, location restrictions, and histological confirmation requirements; proposed randomized, double-blind, placebo-controlled, study design for future studies that are intended to demonstrate the effectiveness of D-MNA in treating BCC; and current safety assessments for the proposed study.

In anticipation of future pivotal studies, the FDA also provided recommendations to continue to optimize formulation and microneedle design, integrate an adhesive layer to affix the microneedle system to the body, and incorporate the use of an applicator to consistently apply the product to the application site.

“Establishing 505(b)(2) as a regulatory pathway to bring to market our novel, non-invasive Skinject D-MNA treatment to cure BCC of the skin, is a game changer” stated Dr. Raza Bokhari, Medicus’s Executive Chairman & CEO, “by leveraging existing doxorubicin safety data, we will not only realize substantial drug development cost savings but also time savings compared to a traditional full development program. As we plan to complete patient recruitment for SKNJCT-003 before the end this year and request an EOP2 meeting with the FDA in Q1 2026, our confidence is increasing that Skinject may become commercially viable sometime in 2027”.

The Company is currently conducting a Phase 2 clinical study for SKNJCT-003 in nine (9) clinical sites across the United States which commenced randomizing patients in August 2024. In March 2025, the Company also announced a positively trending interim analysis for SKNJCT-003 demonstrating more than 60% clinical clearance. The interim analysis was conducted after more than 50% of the then-targeted 60 patients in the study were randomized. The findings of the interim analysis are preliminary and may or may not correlate with the findings of the study once completed. In April 2025, the investigational review board approved to increase the number of participants in SKNJCT-003 to ninety (90) subjects. The Company is expanding its trial sites in Europe and has randomized more than 75% of the ninety (90) participants expected to be randomized in the study.

The Company also has a clinical study (SKNJCT-004) currently underway in the United Arab Emirates (UAE). The study is expected to randomize thirty-six (36) patients in six (6) sites in the UAE. Cleveland Clinic Abu Dhabi (CCAD) is the principal investigator, along with Sheikh Shakbout Medical City (SSMC), Burjeel Medical City (BMC), Rashid Hospital (RH), Clemenceau Medical Center (CMC) and American Hospital of Dubai (AHD). Insights Research Organization and Solutions (IROS), a UAE-based contract research organization, is coordinating the clinical study for the Company. IROS is a M42 portfolio company.

In August 2025, the Company completed the acquisition of Antev, a UK-based late clinical stage biotech company, developing Teverelix, a next generation GnRH antagonist, as a first in market product for cardiovascular high-risk advanced prostate cancer patients and patients with first acute urinary retention relapse (AURr) episodes due to enlarged prostate.

Antev’s flagship drug candidate is Teverelix trifluoroacetate (Teverelix TFA), a long-acting gonadotrophin-releasing hormone (GnRH) antagonist. Unlike GnRH agonists, which can cause an initial surge in testosterone levels, Teverelix directly suppresses sex hormone production without this surge, potentially reducing cardiovascular risks. This mechanism is particularly beneficial for patients with existing cardiovascular conditions. Teverelix is formulated as a microcrystalline suspension, allowing for sustained release and a six-week dosing interval, which may improve patient compliance and outcomes.

For further information contact:

Carolyn Bonner, President and Acting Chief Financial Officer
(610) 636-0184
cbonner@medicuspharma.com

Anna Baran-Djokovic, SVP Investor Relations
(305) 615-9162
adjokovic@medicspharma.com

About Medicus Pharma Ltd.

Medicus Pharma Ltd. (Nasdaq:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets. The Company is actively engaged in multiple countries, spread over three continents.

SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd., is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver a chemotherapeutic agent to eradicate tumors cells. The Company completed a phase 1 safety & tolerability study (SKNJCT-001) in March of 2021, which met its primary objective of safety and tolerability; the study also describes the efficacy of the investigational product D-MNA, with six (6) participants experiencing complete response on histological examination of the resected lesion. The Company is currently conducting a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-003) in the United States and Europe. The Company has also commenced a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-004) in the United Arab Emirates.

In August 2025, the Company announced its entry into a non-binding memorandum of understanding (the “MoU”) with Helix Nanotechnologies, Inc. (“HelixNano”), a Boston Based biotech company focused on developing a proprietary advanced mRNA platform, in respect of their shared mutual interest in the development or commercial arrangement contemplated by the MoU. The MoU is non-binding and shall not be construed to obligate either party to proceed with a joint venture or any further development or commercial arrangement, unless and until definitive agreements are executed.

In August 2025, the Company completed the acquisition of Antev, a UK-based late clinical stage biotech company, developing Teverelix, a next generation GnRH antagonist, as a first in market product for cardiovascular high-risk advanced prostate cancer patients and patients with first acute urinary retention relapse (AURr) episodes due to enlarged prostate.

Antev’s flagship drug candidate is Teverelix trifluoroacetate (Teverelix TFA), a long-acting gonadotrophin-releasing hormone (GnRH) antagonist. Unlike GnRH agonists, which can cause an initial surge in testosterone levels, Teverelix directly suppresses sex hormone production without this surge, potentially reducing cardiovascular risks. This mechanism is particularly beneficial for patients with existing cardiovascular conditions. Teverelix is formulated as a microcrystalline suspension, allowing for sustained release and a six-week dosing interval, which may improve patient compliance and outcomes.

In September 2020, Antev completed a Phase 1 clinical trial in which Teverelix was shown to be well tolerated with no dose-limiting toxicities and demonstrated rapid testosterone suppression. The study included 48 healthy male volunteers. In February 2023, Antev also completed a Phase 2a study in fifty (50) patients with advanced prostate cancer (APC), where Teverelix achieved the primary endpoint of greater than 90% probability of castration levels of testosterone suppression (97.5%) but the secondary endpoint of maintaining this rate above 90% was not met with the probability dropping to 82.5% by Day 42.

In January 2023, the FDA, reviewed the Phase 1 and Phase 2a data and provided written guidance on Antev’s proposed Phase 3 trial design for Teverelix. This milestone supports the Company’s clinical plans to develop Teverelix as a treatment for advanced prostate cancer patients with increased cardiovascular risk.

In December 2023, FDA approved the Phase 2b study design in advanced prostate cancer covering 40 patients.

In November 2024, FDA approved the Phase 2b study design in acute urinary retention covering 390 patients.

Cautionary Notice on Forward-Looking Statements

Certain information in this news release constitutes “forward-looking information” under applicable securities laws. “Forward-looking information” is defined as disclosure regarding possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action and includes, without limitation, the development of Teverelix and expectations concerning, and future outcomes relating to, the development, advancement and commercialization of Teverelix for AURr and high CV risk prostate cancer, and the potential market opportunities related thereto, the MOU, including the potential signing of definitive agreements between Medicus and HelixNano and the development of thermostable infectious diseases vaccines by combining HelixNano’s proprietary mRNA vaccine platform with Medicus’s proprietary microneedle array (MNA) delivery platform, the Company’s aim to fast-track the clinical development program and convert the SKNJCT-003 exploratory clinical trial into a pivotal clinical trial, and approval from the FDA and the timing thereof, plans and expectations concerning, and future outcomes relating to, the development, advancement and commercialization of SkinJect through SKNJCT-003 and SKNJCT-004, and the potential market opportunities related thereto, the commencement of the SKNJCT-004 study and the potential results of and benefits of such study. Forward-looking statements are often but not always, identified by the use of such terms as “may”, “on track”, “aim”, “might”, “will”, “will likely result”, “could,” “designed,” “would”, “should”, “estimate”, “plan”, “project”, “forecast”, “intend”, “expect”, “anticipate”, “believe”, “seek”, “continue”, “target”, “potential” or the negative and/or inverse of such terms or other similar expressions. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including those risk factors described in the Company’s annual report on form 10-K for the year ended December 31, 2024 (the “Annual Report”), and in the Company’s other public filings on EDGAR and SEDAR+, which may impact, among other things, the trading price and liquidity of the Company’s common shares. . Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof and thus are subject to change thereafter. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

SOURCE: Medicus Pharma Ltd

View the original press release on ACCESS Newswire

Targeting Phase 1 commissioning by the end of 2026

HIGHLIGHTS

• Existing fully permitted Central Gawler Mill adjacent to brownfield Challenger mines

• Challenger JORC (2012) Mineral Resources Estimate now 313koz Au (10.6Mt @ 0.92 g/t), including 194koz Au (1.87Mt @ 3.23 g/t) in existing open pit and underground mines, where:

  • Challenger Main Open Pit: 70,000oz Au (0.65Mt @ 3.36 g/t Au);

  • Challenger West Open pit: 11,600oz Au (0.03Mt @ 10.7 g/t Au);

  • Challenger Underground (above 215mRL): 89,400oz Au (0.98Mt @ 2.84 g/t Au); and

  • Challenger Deeps (below 90mRL): 23,000oz Au (0.21Mt @ 3.50 g/t Au).

• Historical tailings storage facility with coarse, higher-grade tailings up to 0.6 – 1.0 g/t Au

• Evaluating de-risked, two phase transition to operations with initial tailings reprocessing (‘Phase 1’) followed by the introduction of high-grade (~3 g/t) fresh ore (‘Phase 2’)

• Targeting Phase 1 commissioning by end of 2026; credit finance conversations underway

ADELAIDE, AU / ACCESS Newswire / September 28, 2025 / Barton Gold Holdings Limited (ASX:BGD)(OTCQB:BGDFF)(FRA:BGD3) (Barton or Company) is pleased to announced that a Definitive Feasibility Study (DFS) has started, targeting ‘Stage 1’ production utilising the fully permitted Central Gawler Mill (CGM) located at Barton’s South Australian Challenger Gold Project (Challenger).

The JORC (2012) Mineral Resource Estimate (MRE) for Challenger was recently upgraded to 313koz Au, including 194koz Au high-grade fresh ore (~3.2 g/t Au) in or adjacent to existing serviceable open pit and underground development, and an historical Tailings Storage Facility 1 (TSF1) containing 56koz Au at a grade of 0.54 g/t Au.²

Barton is targeting March 2026 DFS completion and end of 2026 CGM commissioning, with ‘Phase 1’ operations reprocessing TSF1 materials, and ‘Phase 2’ then introducing fresh ore. Altris Pty Ltd (Altris) has been appointed to lead the DFS, with SRK Consulting (Australasia) Pty Ltd (SRK Consulting) completing TSF1 mining studies, Tetra Tech Coffey Pty Ltd (Tetra Tech Coffey) designing a tailings storage lift, and GPA Engineering Pty Ltd (GPA) supporting engineering, metallurgy and process plant design. Technical site visits will begin this week.

Full details are contained in the complete announcement, which can be accessed on the ASX website, the investor section of Barton’s website, or directly by clicking here.

Commenting on the start of the Stage 1 DFS, Barton Managing Director Alexander Scanlon said:

“With gold prices at all-time highs and over 300koz Au JORC Resources adjacent to the Central Gawler Mill, the opportunity to leverage our existing infrastructure to operations and cash flow has never been more attractive.

“We are wasting no time pursuing this opportunity, targeting a low-cost and low-risk transition to operations by the end of 2026, the re-rating of Barton’s equity to a ‘producer’ profile, and operating free cash flows to fund our planned regional growth at Tunkillia. We look forward to sharing regular updates during an exciting 18 months ahead.”

Authorised by the Managing Director of Barton Gold Holdings Limited.

For further information, please contact:

Alexander Scanlon Managing Director a.scanlon@bartongold.com.au +61 425 226 649

Jade Cook Company Secretary cosec@bartongold.com.au +61 8 9322 1587

About Barton Gold
Barton Gold is an ASX, OTCQB and Frankfurt Stock Exchange listed Australian gold developer targeting future gold production of 150,000ozpa with 2.2Moz Au & 3.1Moz Ag JORC Mineral Resources (79.9Mt @ 0.87g/t Au), brownfield mines, and 100% ownership of the region’s only gold mill in the renowned Gawler Craton of South Australia.*

Challenger Gold Project 313koz Au + fully permitted Central Gawler Mill (CGM) Tarcoola Gold Project 20koz Au in fully permitted open pit mine near CGM Tolmer discovery grades up to 84g/t Au & 17,600g/t Ag Tunkillia Gold Project 1.6Moz Au & 3.1Moz Ag JORC Mineral Resources Competitive 120kozpa gold & 250kozpa silver project Wudinna Gold Project 279koz Au project located southeast of Tunkillia Significant optionality, adjacent to main highway

Competent Persons Statement & Previously Reported Information
The information in this announcement that relates to the historic Exploration Results and Mineral Resources as listed in the table below is based on, and fairly represents, information and supporting documentation prepared by the Competent Person whose name appears in the same row, who is an employee of or independent consultant to the Company and is a Member or Fellow of the Australasian Institute of Mining and Metallurgy (AusIMM), Australian Institute of Geoscientists (AIG) or a Recognised Professional Organisation (RPO). Each person named in the table below has sufficient experience which is relevant to the style of mineralisation and types of deposits under consideration and to the activity which he has undertaken to quality as a Competent Person as defined in the JORC Code 2012 (JORC).

Activity	Competent Person	Membership	Status
Tarcoola Mineral Resource (Stockpiles)	Dr Andrew Fowler (Consultant)	AusIMM	Member
Tarcoola Mineral Resource (Perseverance Mine)	Mr Ian Taylor (Consultant)	AusIMM	Fellow
Tarcoola Exploration Results (until 15 Nov 2021)	Mr Colin Skidmore (Consultant)	AIG	Member
Tarcoola Exploration Results (after 15 Nov 2021)	Mr Marc Twining (Employee)	AusIMM	Member
Tunkillia Exploration Results (until 15 Nov 2021)	Mr Colin Skidmore (Consultant)	AIG	Member
Tunkillia Exploration Results (after 15 Nov 2021)	Mr Marc Twining (Employee)	AusIMM	Member
Tunkillia Mineral Resource	Mr Ian Taylor (Consultant)	AusIMM	Fellow
Challenger Mineral Resource (above 215mRL)	Mr Ian Taylor (Consultant)	AusIMM	Fellow
Challenger Mineral Resource (below 90mRL)	Mr Dale Sims	AusIMM / AIG	Fellow / Member
Wudinna Mineral Resource (Clarke Deposit)	Ms Justine Tracey	AusIMM	Member
Wudinna Mineral Resource (all other Deposits)	Mrs Christine Standing	AusIMM / AIG	Member / Member

The information relating to historic Exploration Results and Mineral Resources in this announcement is extracted from the Company’s Prospectus dated 14 May 2021 or as otherwise noted in this announcement, available from the Company’s website at www.bartongold.com.au or on the ASX website www.asx.com.au. The Company confirms that it is not aware of any new information or data that materially affects the Exploration Results and Mineral Resource information included in previous announcements and, in the case of estimates of Mineral Resources, that all material assumptions and technical parameters underpinning the estimates, and any production targets and forecast financial information derived from the production targets, continue to apply and have not materially changed. The Company confirms that the form and context in which the applicable Competent Persons’ findings are presented have not been materially modified from the previous announcements.

Cautionary Statement Regarding Forward-Looking Information

This document may contain forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “expect”, “target” and “intend” and statements than an event or result “may”, “will”, “should”, “would”, “could”, or “might” occur or be achieved and other similar expressions. Forward-looking information is subject to business, legal and economic risks and uncertainties and other factors that could cause actual results to differ materially from those contained in forward-looking statements. Such factors include, among other things, risks relating to property interests, the global economic climate, commodity prices, sovereign and legal risks, and environmental risks. Forward-looking statements are based upon estimates and opinions at the date the statements are made. Barton undertakes no obligation to update these forward-looking statements for events or circumstances that occur subsequent to such dates or to update or keep current any of the information contained herein. Any estimates or projections as to events that may occur in the future (including projections of revenue, expense, net income and performance) are based upon the best judgment of Barton from information available as of the date of this document. There is no guarantee that any of these estimates or projections will be achieved. Actual results will vary from the projections and such variations may be material. Nothing contained herein is, or shall be relied upon as, a promise or representation as to the past or future. Any reliance placed by the reader on this document, or on any forward-looking statement contained in or referred to in this document will be solely at the readers own risk, and readers are cautioned not to place undue reliance on forward-looking statements due to the inherent uncertainty thereof.

SOURCE: Barton Gold Holdings Limited

View the original press release on ACCESS Newswire